-+ 0.00%
-+ 0.00%
-+ 0.00%
What Philip Morris International Doubters Overlooked
Share
Listen to the news

If Philip Morris International was on your watchlist instead of in your account, this year’s move may feel like a missed call. Investors who held Philip Morris International from the start of the year are up 23.4%, including dividends. That outcome followed a flood of headlines on smoke-free products, FDA decisions and fresh guidance. The real question is simpler, though. Back on 2026-01-01, how confident could you reasonably be that smoke-free momentum would support those earnings assumptions?

Philip Morris International has already moved. See which of 35 high quality undervalued stocks still trade below our estimates.

The Two Philip Morris International Stories Investors Were Choosing Between

The shares cost US$160 at the start of the period, which left holders weighing two very different stories about what Philip Morris International might deliver.

On the optimistic side, one narrative pointed to a Fair Value of US$190, a price that depended on assumptions such as revenue climbing 8.2% a year and profit margins reaching 29.3% as smoke-free products gained ground.

The more cautious view centered on a Fair Value of US$151, built on concerns that tighter regulation and public health pressure could restrain demand even if margins improved.

NYSE:PM Trailing 12-Month Earnings & Revenue History as at Nov 2026
NYSE:PM Trailing 12-Month Earnings & Revenue History as at Nov 2026

What The Results Put To The Test For Philip Morris International

FDA modified risk status for ZYN and renewed authorization for IQOS backed the Philip Morris International bull case that smoke free products could support higher quality earnings. The counterpoint was in the numbers. Between Q3 2025 and Q3 2026, revenue rose from US$10,845m to US$11,438m while net income slipped and net margin moved from 32.0% to 28.9%. The evidence cut both ways.

The lesson is clear. When a thesis hangs on better profitability, do not just watch new product approvals. Instead, track whether net income and margin trends actually move toward the forecasted level.

What Philip Morris International's Price Now Assumes

Philip Morris International now trades at US$193 after a 23.4% gain from the start of the year. The bearish analyst Narrative on Simply Wall St sees its fair value below that level and argues the current tag already bakes in a lot of smoke free execution.

That Narrative asks what must keep going right. A buyer today would need confidence that smoke free volumes, pricing power and regulation all stay supportive enough to maintain revenue and margin strength.

"Although Philip Morris International continues to report strong organic growth in smoke free products with double digit revenue and gross profit contributions, the estimated 26.5% premium to intrinsic value flagged in July 2026 suggests that even a modest slowdown in this shift from combustibles could leave revenue and earnings growth insufficient to justify the current valuation."

That disagreement has a full argument behind it. → Uncover the lower Fair Value this Narrative argues for

Find Your Own Contrarian Opportunity

What if your next investment idea came before the headlines? Go straight to the companies whose prices and our estimates still disagree. Three places to start, with the names waiting behind the link.

  • Company 1 - 16% below our estimate - supplies high bandwidth memory enabling data-intensive AI accelerator performance in systems.
  • Company 2 - 35% below our estimate - ties subscription software and AI services to shared, scalable cloud infrastructure capacity.
  • Company 3 - 42% below our estimate - converts subsea opportunity lists into faster tieback projects and recurring offshore service work.

That is three of the list. See the full list of 24 financially solid companies →

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending